Yili Chuanning Biotechnology Co.,Ltd. (SHE:301301)
China · Delayed Price · Currency is CNY 8.72
+0.06 (0.69%)
At close: Jul 31, 2026
SHE:301301 Market Cap
SHE:301301 has a market cap or net worth of 19.47 billion as of July 31, 2026. Its market cap has decreased by -30.89% in one year.
Market Cap
19.47B
Enterprise Value
20.05B
Revenue
4.41B
Ranking
n/a
PE Ratio
33.33
Stock Price
8.72
ChartMarket Cap Chart
Since December 27, 2022, SHE:301301's market cap has decreased from 22.34B to 19.47B, a decrease of -12.86%. That is a compound annual growth rate of -3.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 19.47B | -13.92% |
| Dec 31, 2025 | 22.61B | -14.39% |
| Dec 31, 2024 | 26.41B | 41.47% |
| Dec 29, 2023 | 18.67B | -6.15% |
| Dec 30, 2022 | 19.89B | -10.95% |
| Dec 27, 2022 | 22.34B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chongqing Zhifei Biological Products | 30.23B |
| Beijing Tiantan Biological Products | 24.84B |
| Hualan Biological Engineering | 24.21B |
| Xiamen Amoytop Biotech | 23.55B |
| Hebei Changshan Biochemical Pharmaceutical | 22.94B |
| Sinocelltech Group | 16.08B |
| BrightGene Bio-Medical Technology | 14.60B |
| Anhui Anke Biotechnology (Group) | 13.69B |